Research Article

Injectable Thermosensitive GelMA/β-Glycerophosphate Hydrogel for Sustained Local Delivery of Metronidazole in Periodontal Therapy

Authors

  • Fatemeh Fasihi * School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Fatemeh zeinali Morvarid Intelligent Industrial Systems Research Group, Iran.

https://doi.org/10.48313/bic.vi.86

Abstract

Local delivery of antimicrobial agents can improve periodontal therapy by prolonging drug residence at the infection site while limiting systemic exposure. This study developed an injectable thermosensitive GelMA/β-Glycerophosphate (β-GP) hydrogel for sustained local delivery of Metronidazole (MTZ). GelMA/β-GP formulations were evaluated for temperature-responsive gelation, injectability, rheological properties, swelling, degradation, drug encapsulation, and in vitro release. Antibacterial activity against Porphyromonas Gingivalis (P. gingivalis) and cytocompatibility toward human gingival fibroblasts were also investigated. The optimized formulation containing 10% (w/v) GelMA and 4% (w/v) β-GP exhibited a gelation temperature of 34.2±0.8°C and formed a stable gel within 4.1±0.4 min at 37°C. MTZ Encapsulation Efficiency (EE%) was 82.6±2.8%, with 76.3±3.5% cumulative release after 168 h. The release profile was best described by the Korsmeyer–Peppas model (R²=0.987; n = 0.68±0.04), indicating predominantly diffusion-controlled release with polymer relaxation. The MTZ-loaded hydrogel showed 86.4±2.7% inhibition of P. gingivalis, while fibroblast viability remained above 94%. The optimized hydrogel demonstrated suitable thermoresponsive gelation, sustained MTZ release, antibacterial activity, and favorable preliminary cytocompatibility, supporting its potential as a localized periodontal drug-delivery platform.

Keywords

β-glycerophosphate Thermosensitive hydrogel Metronidazole Drug delivery Porphyromonas gingivalis cytocompatibility GelMA
References (29)
  1. [1] Nagaraj, A., Etxeberria, A. E., Naffa, R., Zidan, G., & Seyfoddin, A. (2022). 3D-printed hybrid collagen/GelMA hydrogels for tissue engineering applications. Biology, 11(11), 1561. https://doi.org/10.3390/biology11111561

  2. [2] Kulkarni, N. S., Chauhan, G., Goyal, M., Sarvepalli, S., & Gupta, V. (2022). Development of gelatin methacrylate (GelMa) hydrogels for versatile intracavitary applications. Biomaterials Science, 10(16), 4492–4507. https://doi.org/10.1039/d2bm00022a

  3. [3] Liu, Y., Li, T., Sun, M., Cheng, Z., Jia, W., Jiao, K., ... & Luo, Y. (2022). ZIF-8 modified multifunctional injectable photopolymerizable GelMA hydrogel for the treatment of periodontitis. Acta Biomaterialia, 146, 37-48. https://doi.org/10.1016/j.actbio.2022.03.046

  4. [4] Yi, S., Liu, Q., Luo, Z., He, J. J., Ma, H. L., Li, W., ... & Zhang, Y. S. (2022). Micropore‐forming gelatin methacryloyl (GelMA) bioink toolbox 2.0: Designable tunability and adaptability for 3D bioprinting applications. Small, 18(25), 2106357. https://doi.org/10.1002/smll.202106357

  5. [5] Zhou, B., Jiang, X., Zhou, X., Tan, W., Luo, H., Lei, S., & Yang, Y. (2023). GelMA-based bioactive hydrogel scaffolds with multiple bone defect repair functions: Therapeutic strategies and recent advances. Biomaterials Research, 27(1), 86. https://doi.org/10.1186/s40824-023-00422-6

Article Metrics

How to Cite

Fasihi, F. ., & zeinali, F. . (2026). Injectable Thermosensitive GelMA/β-Glycerophosphate Hydrogel for Sustained Local Delivery of Metronidazole in Periodontal Therapy. Biocompounds, 3(4), 334-361. https://doi.org/10.48313/bic.vi.86

Similar Articles

1-10 of 39

You may also start an advanced similarity search for this article.